LeConte Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
LeConte Wealth Management's LLY Position: Q3 2026 in Review
LeConte Wealth Management increased its Eli Lilly (LLY) stake by 11% in Q3 2026, buying an estimated $139K and bringing the position to 1,162 shares worth $1.34M. The position accounts for 0.72% of the portfolio, ranked #34.
LeConte Wealth Management first reported a position in LLY in Q1 2025 and has held it in 7 quarters since. 1,633 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- LeConte Wealth Management held 1,162 shares of Eli Lilly worth $1.34M as of Q3 2026.
- LeConte Wealth Management bought 118 Eli Lilly shares in Q3 2026, an estimated $139K.
- Eli Lilly made up 0.72% of LeConte Wealth Management's portfolio in Q3 2026, its #34 holding.
- LeConte Wealth Management first reported a position in Eli Lilly in Q1 2025 and has held it in 7 quarters since.
- 1,633 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on LeConte Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.